Unknown

Dataset Information

Comparison of the multiples of the median of serum anti-mullerian hormone and pregnancy outcomes in patients with gestational trophoblastic disease: A case-control study.


ABSTRACT:

Introduction

Chemotherapy is crucial in treating gestational trophoblastic neoplasia (GTN), but its impact on gonadotoxicity is unclear.

Materials and methods

This case-control study included 57 GTN patients and 19 age-matched patients with molar pregnancies (MP) in 2012-2018. Multiples of the median (MoM) of the serum AMH levels were compared between the two groups, and between patients using single-agent and combination chemotherapy, at baseline, 6, 12, and 24 months after treatment. Their pregnancy outcomes were also compared.

Results

There was no significant difference in the MoM of serum AMH between GTN and MP groups at all time points. Single-agent chemotherapy did not adversely affect the MoM. However, those receiving combination chemotherapy had lower MoM than

SUBMITTER: Lai THT 

PROVIDER: S-EPMC10973878 | biostudies-literature | 2024 Apr

REPOSITORIES: biostudies-literature